Eksportal powder for solution inside the pack 10d. 20 pc

$12.34

Eksportal powder for solution inside the pack 10d. 20 pc

Quantity:

SKU: 1591987055 Categories: , , Tag:

Description

Composition
Active substance:
1 sachet contains: lactitol monohydrate – 5 g or 10 g per sachet, 200 g or 500 g in a plastic container. Without adjuvants.
Description:
The white crystalline powder.
Product form:
powder for solution for oral administration. 5 g or 10 g monodose bags (sachets) made of paper coated with polyethylene or Buflena – composite material based on paper, aluminum and polyethylene, the bag 2 (sachets) are connected to one strip (separated by apertured strip).
At 3, 6 or strips 6, 12 bags (sachets) to 5 g, or at 5, 10 or strips 10, 20 bags (sachet) 10 g together with instructions for use placed in a pile of cardboard.
200 or 500 g in a plastic container. Instructions for use adheres to the container.
Contraindications
Hypersensitivity to lactitol.
Lactase deficiency, fructose and galactose intolerance, galactosemia, a syndrome of glucose-galactose malabsorption.
Syndrome full or partial bowel obstruction, suspected organic injury of the gastrointestinal tract, and abdominal pain, rectal bleeding of unknown origin, inflammatory bowel disease (rectocolitis, regional enteritis) prior to disruption of water-electrolyte balance.
Children under 1 year.
Carefully.
Eksportal® should be used with caution in patients prone to violations of water-salt balance.
Indications
Constipation, the need to regulate the chair for medical purposes (bowel cleansing in preparation for endoscopic and radiologic studies, surgery on the rectum, anal sphincter and the area adjacent to it), intestinal dysbiosis. Hepatic encephalopathy, liver precoma and coma, hyperammonemia.
Interaction with other drugs
In simultaneous reception Eksportala® preparations with enteric pH-dependent release should be considered that lactitol reduces the pH of the intestine.
Eksportal® not recommended for two hours after the administration of other medicaments.
Overdose
Symptoms include diarrhea, abdominal pain, in rare cases, possible vomiting. These phenomena are usually eliminated reduction in dose.
Treatment: dose reduction or withdrawal of the drug. Correction of possible violations of water-salt balance.
pharmachologic effect
Pharmacological group:
Laxative.
Pharmacological properties:
In colon lactitol cleaved by intestinal flora to low molecular weight organic acids, which leads to an increase of osmotic pressure in the colon, increased stool volume, their softening facilitate defecation and normalize bowel function. The laxative effect generally occurs within 24 hours after treatment (delayed due to the passage of drug through the gastrointestinal tract). In the early course of treatment may be a delay laxative effect of the drug, the effect may occur at the second or third day of application.
In patients with hepatic encephalopathy and hepatic coma (or precoma) effect is achieved due to the migration of blood ammonia in the colon (by reducing the pH, increasing the osmotic pressure in the lumen of the intestine), the removal of the colon detained ammonium ions and other toxic nitrogen compounds. Lactitol inhibits proteolytic bacteria, and increases the number of acidophilic bacteria.
Pharmacokinetics:
Lactitol carries out its effects only in the large intestine, where it gets completely after oral administration. It is absorbed in minimal amounts in unmodified form (not more than 0.5 – 2% of the dose).
Pregnancy and breast-feeding
In view of the minimal intake of lactitol, any adverse effects on the woman and the fetus when administered during pregnancy is not expected. The drug can be taken during pregnancy unless the potential benefit to the mother outweighs the potential risk to the fetus.
Because of the minimal absorption, penetration of lactitol in breast milk is not expected. The drug can be taken during breast-feeding if the potential benefit to the mother outweighs the potential risk to the child.
Conditions of supply of pharmacies
Without recipe.
side effects
At the beginning of treatment may develop discomfort in the abdomen, bloating and, in rare cases, abdominal pain and bloating. These phenomena tend to fade with continued use of the drug, as the adaptation.
In the case of high doses for long time in the treatment of hepatic encephalopathy in the patient due to diarrhea, electrolyte imbalances can occur.
Because of individual differences, some patients may experience diarrhea, even when receiving the recommended dose of the drug. In this case it is necessary to reduce the dose of the drug.
The frequency of side effects is classified in accordance with the recommendations of the World Health Organization: very often – at least 10%; often – at least 1% but less than 10%; infrequently – at least 0.1% but less than 1%; rarely – at least 0.01% but less than 0.1%; very rarely – less than 0.01%; unknown frequency – can not be estimated from available data.
Disorders of the gastrointestinal tract
Rare: flatulence, abdominal pain, bloating, vomiting, diarrhea.
Very rare: nausea, pruritus.
special instructions
Lactitol has a low calorie (2 kcal / g) does not affect the blood glucose level and can be used in patients with diabetes.
Throughout the course of the drug desirably increased fluid intake.
Application Eksportala® no effect on psychomotor functions related to driving or control machines and mechanisms.
Storage conditions
In dry, protected from light and out of reach of children.
Dosing and Administration
Inside during meal time by mixing with a variety of drinks (water, tea, coffee, juice et al.) Or liquid food.
Constipation and dysbacteriosis. The drug should be taken once, the entire daily dose at once, at one time.
Children 1 -6 -2.5 years – 5 g (2.1 – 1 teaspoon powder) per day.
Children 6 to 12 years -5 – 10 g (1 – 2 heaping tablespoons of powder) per day.
Children 12 years -16 -10 – 20 g of (2 – 4 teaspoon of powder) per day.
Adults: 20 g (4 tablespoons tea powder) per day.
The drug should cause the chair once a day; stable after the laxative effect within a few days of the drug, the dose can be reduced. In some cases, the desired effect is sufficient is half of the recommended daily dose. Minimum course of therapy, after which should consult a doctor -5 months. Use of the drug in children recommended under medical supervision.
When adjusting the chair for medical purposes.
20 g of the drug, dissolved in 1 liter of water, taken three times (in 12, 15 and 18 hours) the day before medical procedures.
In hepatic encephalopathy, hepatic coma and precoma, hyperammonemia.
The dose should be adjusted individually for each patient depending on the severity of the disease and the individual response to the drug. The initial daily dose is usually 0.5-0.7 g per 1 kg of body weight. This dose is divided into three single doses. Taken with food. It should be adjusted dose causing two “soft” chair per day.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg
Manufacturer

Valenta Pharm

There are no reviews yet.

Add your review